Viewing Study NCT00335205


Ignite Creation Date: 2025-12-25 @ 3:15 AM
Ignite Modification Date: 2025-12-26 @ 1:54 AM
Study NCT ID: NCT00335205
Status: UNKNOWN
Last Update Posted: 2006-06-09
First Post: 2006-06-08
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: A Placebo Controlled Trial of the Dopamine D-2 Receptor Agonist Ropinirole in Treatment of 60 Patients With Refractory Bipolar Depression.
Sponsor: Sheba Medical Center
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module